Efficacy and toxicity of dexamethasone vs methylprednisolone-long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002.
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.|Department of Oncology, Hematology and radiotherapy, Pirogov Russian National Research Medical University, Moscow, Russia.
A
A
Karachunskiy
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.|Department of Oncology, Hematology and radiotherapy, Pirogov Russian National Research Medical University, Moscow, Russia.
J
J
Roumiantseva
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
S
S
Lagoiko
Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
C
C
Bührer
Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
G
G
Tallen
Republic Clinical Research Centre for Pediatric Oncology and Hematology, Minsk, Belarus.
O
O
Aleinikova
Republic Clinical Research Centre for Pediatric Oncology and Hematology, Minsk, Belarus.
O
O
Bydanov
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
N
N
Korepanova
Federal Central Russian Children Hospital, Moscow, Russia.
L
L
Bajdun
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.|Engelhardt Institute of Molecular Biology Russian Academy of Sciences, Moscow, Russia.
T
T
Nasedkina
Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
A
A
von Stackelberg
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.|Department of Oncology, Hematology and radiotherapy, Pirogov Russian National Research Medical University, Moscow, Russia.
G
G
Novichkova
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.|Department of Oncology, Hematology and radiotherapy, Pirogov Russian National Research Medical University, Moscow, Russia.
A
A
Maschan
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.|Department of Oncology, Hematology and radiotherapy, Pirogov Russian National Research Medical University, Moscow, Russia.
D
D
Litvinov
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
N
N
Myakova
Federal Central Russian Children Hospital, Moscow, Russia.
N
N
Ponomareva
Department of Oncology, Hematology and radiotherapy, Pirogov Russian National Research Medical University, Moscow, Russia.|Department of Pediatric Hematology, Morozov Children's Hospital, Moscow, Russia.
K
K
Kondratchik
Paediatric Oncohematological Centre, Regional Children's Hospital, Ekaterinburg, Russia.
L
L
Fechina
Paediatric Oncohematological Centre, Regional Children's Hospital, Ekaterinburg, Russia.
O
O
Streneva
Department of Pediatric Oncology/Hematology, Regional Children's Hospital, Voronezh, Russia.
N
N
Judina
Department of Pediatric Oncology/Hematology, Regional Children's Hospital, Nizhnevartovsk, Russia.
G
G
Scharapova
Department of Pediatric Hematology, Regional Children's Hospital, Nizhni Novgorod, Russia.
A
A
Shamardina
Department of Pediatric Oncology/Hematology, Regional Children's Hospital, Tomsk, Russia.
I
I
Gerbek
Department of Pediatric Oncology/Hematology, Regional Oncological Hospital, Orenburg, Russia.
A
A
Shapochnik
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.|Department of Oncology, Hematology and radiotherapy, Pirogov Russian National Research Medical University, Moscow, Russia.
A
A
Rumjanzew
Federal Clinical Research Centre for Pediatric Hematology, Oncology and Immunology, Moscow, Russia.|Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
G
G
Henze
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D015337:Multicenter Studies as Topic; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012426:Russia; D013997:Time Factors
D003907:Dexamethasone; D008775:Methylprednisolone